logo

For the Inventor, By the Inventor

Bordeaux, France

Phillippe Mauclere

This inventor holds 4 USPTO granted patents. Top assignees: National Institute of Health and Medical Research, Assistance Publique-Hopitaux De Paris, Institut Pasteur. Active years: 2003-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phillippe Mauclere. Retrieved from https://idiyas.com/inventor/phillippe-mauclere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal4 out of 1,853 
 
National Institute of Health and Medical Research
 patents
silverMedal2 out of 331 
 
Assistance Publique-Hopitaux De Paris
 patents
bronzeMedal2 out of 898 
 
Institut Pasteur
 patents
where one patent can have more than one assignee

Years Active: 2003-2012

Loading Chart...
4 patents (USPTO):Explore Patents
1. 8227185 - Non-M, non-O HIV-1 strains, fragments and uses (2012-07-24),
2. 7534877 - Non-M, non-O HIV-1 strains, fragments and uses (2009-05-19),
3. 7030234 - Non-M, non-O HIV-1 strains, fragments and uses (2006-04-18),
4. 6509018 - Non-M non-O HIV strains, fragments and uses (2003-01-21),

Title: The Innovations of Phillippe Mauclere

Introduction

Phillippe Mauclere is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of medical research, particularly in the study of HIV-1 strains. With a total of 4 patents to his name, his work has had a profound impact on diagnostics and immunogenic applications.

Latest Patents

Mauclere's latest patents focus on non-M, non-O HIV-1 strains and their fragments. One of his key inventions is a retroviral strain designated YBF30, which serves as a diagnostic reagent and an immunogenic agent. This strain, along with another designated YBE30, exhibits unique characteristics that differentiate it from both the M and O groups of HIV-1 viruses. These innovations are crucial for advancing the understanding and treatment of HIV.

Career Highlights

Throughout his career, Mauclere has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and Assistance Publique-Hôpitaux de Paris. His research has been instrumental in developing new methodologies for diagnosing and treating HIV infections.

Collaborations

Mauclere has collaborated with esteemed colleagues, including Ibtissam Loussert-Ajaka and Francois Simon. These partnerships have further enriched his research and contributed to the advancement of medical science.

Conclusion

Phillippe Mauclere's contributions to the field of HIV research through his patents and collaborations highlight his importance as an inventor. His work continues to pave the way for innovative solutions in the fight against HIV.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…